Could Preemption Hurt Drug Companies? Published: Nov 11, 2008 Forbes -- Here's some heresy: Could winning a battle against the plaintiff's bar actually hurt pharmaceutical companies over the long haul? Related links Forbes This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news